跳至主要内容
临床试验/NCT00273728
NCT00273728已完成4 期

Basel Study for Evaluation of Starch (130;0.4) Infusion in Septic Patients: BaSES (130;0.4) Trial

University Hospital, Basel, Switzerland2 个研究点 分布在 1 个国家目标入组 231 人开始时间: 2005年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
231
试验地点
2
主要终点
Intensive Care length of stay

研究概览

简要总结

Background: In patients with severe sepsis and septic shock early aggressive volume replacement reduced mortality. Standard infusion therapy consists of crystalloid infusions. The role of modern, low molecular weight, starch preparations and their influence on the course of disease is not determined yet.

Hypothesis: The purpose of this study is to determine wether initial infusion therapy with Hydroxyethylstarch and Ringer's lactate reduces in septic patients reduces Intensive Care Unit and hospital length of stay without impairment of renal function

Design: Double-blind, randomized, controlled monocentric study

Setting: Intensive Care Units of a University Hospital

Patients: 240 consecutive patients with sepsis, severe sepsis and septic shock

Intervention: Volume therapy with Ringer's lactate and saline or hydroxy-ethyl starch (MW 130, substitution 0.4) in the first five days of intensive care treatment.

Parameter:

  • Intensive Care length of stay
  • Hospital length of stay
  • Mortality
  • Kidney function

Statistics: Mann-Whitney test for non-parametric data like intensive care length of stay. Unpaired t-Test for kidney function parameters.

Study withdrawal: Significant impairment of kidney function parameters in the hydroxy-ethyl starch group

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with suspected or proven infection and 2 of the following 6 criteria:
  • Body temperature <36 or >38.3° celsius
  • Heart rate > 90 beats/min
  • Tachypnea > 20/min or a arterial pCO2 below 4.25 kPa
  • White blood cell count higher than 12.000 or below 4.000 or more than 10% immature forms
  • Systolic blood pressure <90 mmHg or mean arterial pressure < 65 mmHg
  • Altered mental state or oliguria

排除标准

  • Pregnancy
  • Age below 18
  • Allergy against Hydroxyethyl starch
  • Chronic renal insufficiency

研究组 & 干预措施

HES, Septic shock, resuscitation

Active Comparator

study group with HES 6%

干预措施: hydroxy-ethyl starch (MW 130; 0.4) vs. normal saline (Drug)

结局指标

主要结局

Intensive Care length of stay

时间窗: time to discharge from the Intensive care unit

Hospital length of stay

时间窗: time to discharge from the hospital

Mortality

时间窗: intesive care, hospital and one year mortality

次要结局

  • Kidney function(at intensive care discharge and after one year)
  • Lung function(during intensive care)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other

研究点 (2)

Loading locations...

相似试验